Is this promising growth stock about to break out and become the next Fevertree Drinks?

Team17 Group plc (LON:TM17) is a high-growth stock in one of the UK’s fastest growing industries, and could be about to take off!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since its IPO in 2014, Fever-Tree Drinks has rocketed from 165p to around 3000p.  Identifying the right small-cap growth stock could be the thing that helps you retire early.

Team 17’s (LSE: TM17) business strategy extends far beyond simply designing and selling videogames.  Since 1990, it has acted as an independent publishing label for gaming studios around the world, collaborating to aid with the development, marketing and sales of titles such as the famous Worms series and Genesis Alpha One.

Peaks & Troughs

Those who invested early since the IPO in May 2018 have been on a roller-coaster of peaks and troughs, but the market could finally be settling into a consistent upward trend. Financial results in March showed increased revenue from £29.6m in 2017 to £43.2m in 2018 – that’s a 46% lift! Earnings per share increased by 42%, demonstrating that earnings increases are being reflected in gains for investors. Since issuing the results, the stock has grown 14% from 232p to 265p.  It’s quite possible that it is about to break out further, and now could be the perfect time to get on board…

Long-Term Prospects

Whilst the short term looks promising, investors could continue to be in for a bumpy ride. But the long-term outlook is promising as well.  Gaming is a huge industry, and only looks to expand as new markets in emerging economies continue to develop.  What’s more, Team 17’s focus on independent developers allows the more creative elements of the industry to establish great content at a fast pace and also entails a low-risk, high-yield approach to its releases. Rather than having to go all in on high-cost projects like companies such as Activision Blizzard do, Team 17’s strategy is to go for a wide range of small projects with high sales opportunities. Certainly, this is reflected in the revenue growth story so far.

Led by a Market Veteran

A further encouraging sign lies in the CEO: Deborah Bestwick, MBE.  A leading figure in both the entrepreneurial and video gaming worlds, Bestwick has over 25 years’ experience in the industry, having won “Businesswoman of the Year” in 2016 from the Annual Women in Games conference. Still owning 22% of the company, Bestwick is a CEO with a formidable track record and skin in the game.

Conclusion

With a P/E ratio of 24.1, the stock might look on the expensive side, but on a PEG reading of 0.40, I believe the stock looks undervalued if the growth story plays out, and the latest set of results seem to suggest just that.  

AIM stocks are high risk and volatile, but if you can stomach the high peaks and troughs that Team 17’s stock price could continue to experience, this could be a long-term investment to rival the returns of Fever-Tree Drinks.

David Maggs holds positions in Fevertree, Team17 and Activision. The Motley Fool UK does not own shares in any companies mentioned in this article. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »